Kendra D. Carter

Array ( [id] => 8956043 [patent_doc_number] => 08501817 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-08-06 [patent_title] => 'Stabilized compositions of alkylating agents and methods of using same' [patent_app_type] => utility [patent_app_number] => 12/401812 [patent_app_country] => US [patent_app_date] => 2009-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 6 [patent_no_of_words] => 15224 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12401812 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8956043 [patent_doc_number] => 08501817 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-08-06 [patent_title] => 'Stabilized compositions of alkylating agents and methods of using same' [patent_app_type] => utility [patent_app_number] => 12/401812 [patent_app_country] => US [patent_app_date] => 2009-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 6 [patent_no_of_words] => 15224 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12401812 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5539898 [patent_doc_number] => 20090221703 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-03 [patent_title] => 'HIGH PENETRATION COMPOSITION AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/397308 [patent_app_country] => US [patent_app_date] => 2009-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 12268 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0221/20090221703.pdf [firstpage_image] =>[orig_patent_app_number] => 12397308 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5539910 [patent_doc_number] => 20090221715 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-03 [patent_title] => 'NOVEL POLYMORPH OF ATOVAQUONE' [patent_app_type] => utility [patent_app_number] => 12/394419 [patent_app_country] => US [patent_app_date] => 2009-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 3179 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0221/20090221715.pdf [firstpage_image] =>[orig_patent_app_number] => 12394419 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6039515 [patent_doc_number] => 20110092564 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-21 [patent_title] => 'CYCLIC AMINO ACIDS FOR THE TREATMENT OF PAIN' [patent_app_type] => utility [patent_app_number] => 12/919657 [patent_app_country] => US [patent_app_date] => 2009-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 11539 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20110092564.pdf [firstpage_image] =>[orig_patent_app_number] => 12919657 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8577812 [patent_doc_number] => 08344022 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-01-01 [patent_title] => 'Vaginal health products' [patent_app_type] => utility [patent_app_number] => 12/364673 [patent_app_country] => US [patent_app_date] => 2009-02-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 11 [patent_no_of_words] => 16463 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 104 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12364673 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9086443 [patent_doc_number] => 08557872 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-10-15 [patent_title] => 'Compounds, isomer thereof, or pharmaceutically acceptable salts thereof as vanilloid receptor antagonist; and pharmaceutical compositions containing the same' [patent_app_type] => utility [patent_app_number] => 12/865082 [patent_app_country] => US [patent_app_date] => 2009-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29290 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 536 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12865082 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4442532 [patent_doc_number] => 07928130 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-04-19 [patent_title] => 'Isoxazoline compounds having MIF antagonist activity' [patent_app_type] => utility [patent_app_number] => 12/360290 [patent_app_country] => US [patent_app_date] => 2009-01-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 10993 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/928/07928130.pdf [firstpage_image] =>[orig_patent_app_number] => 12360290 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8435570 [patent_doc_number] => 08283339 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-10-09 [patent_title] => 'Vinyl phosphonate lysophosphatidic acid receptor antagonists' [patent_app_type] => utility [patent_app_number] => 12/357728 [patent_app_country] => US [patent_app_date] => 2009-01-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 40 [patent_figures_cnt] => 138 [patent_no_of_words] => 23029 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12357728 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5403449 [patent_doc_number] => 20090238763 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-24 [patent_title] => 'HIGH PENETRATION COMPOSITIONS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/351804 [patent_app_country] => US [patent_app_date] => 2009-01-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 56 [patent_figures_cnt] => 56 [patent_no_of_words] => 55932 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0238/20090238763.pdf [firstpage_image] =>[orig_patent_app_number] => 12351804 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7729982 [patent_doc_number] => 08101665 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-01-24 [patent_title] => 'Process for synthesis of tritiated and deuterated thiorphan and acetorphan' [patent_app_type] => utility [patent_app_number] => 12/316946 [patent_app_country] => US [patent_app_date] => 2008-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7111 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/101/08101665.pdf [firstpage_image] =>[orig_patent_app_number] => 12316946 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5480739 [patent_doc_number] => 20090203696 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-13 [patent_title] => 'Aryl- and Heteroaryl-Ethyl-Acylguanidine Derivatives, Their Preparation and Their Application in Therapeutics' [patent_app_type] => utility [patent_app_number] => 12/335198 [patent_app_country] => US [patent_app_date] => 2008-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28460 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0203/20090203696.pdf [firstpage_image] =>[orig_patent_app_number] => 12335198 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5368492 [patent_doc_number] => 20090306051 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-10 [patent_title] => 'Methods and compositions for the treatment of epilepsy, seizure disorders, and other CNS disorders' [patent_app_type] => utility [patent_app_number] => 12/333121 [patent_app_country] => US [patent_app_date] => 2008-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 10243 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0306/20090306051.pdf [firstpage_image] =>[orig_patent_app_number] => 12333121 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5987086 [patent_doc_number] => 20110098296 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-28 [patent_title] => 'Thiazole And Oxazole Kinase Inhibitors' [patent_app_type] => utility [patent_app_number] => 12/746826 [patent_app_country] => US [patent_app_date] => 2008-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 106570 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 32 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0098/20110098296.pdf [firstpage_image] =>[orig_patent_app_number] => 12746826 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6536575 [patent_doc_number] => 20100204202 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-12 [patent_title] => 'DRUG FOR ALLEVIATING MOTOR COMPLICATIONS OR PSYCHIATRIC SYMPTOMS OF PARKINSON\'S DISEASE' [patent_app_type] => utility [patent_app_number] => 12/673786 [patent_app_country] => US [patent_app_date] => 2008-11-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 20882 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0204/20100204202.pdf [firstpage_image] =>[orig_patent_app_number] => 12673786 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5324412 [patent_doc_number] => 20090062402 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-05 [patent_title] => 'ACTIVE SUBSTANCE COMBINATION OF LICOCHALCONE A AND PHENOXYETHANOL' [patent_app_type] => utility [patent_app_number] => 12/270009 [patent_app_country] => US [patent_app_date] => 2008-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14282 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0062/20090062402.pdf [firstpage_image] =>[orig_patent_app_number] => 12270009 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7687547 [patent_doc_number] => 20090176744 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-09 [patent_title] => 'Deuterated fingolimod' [patent_app_type] => utility [patent_app_number] => 12/290645 [patent_app_country] => US [patent_app_date] => 2008-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11007 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0176/20090176744.pdf [firstpage_image] =>[orig_patent_app_number] => 12290645 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6402560 [patent_doc_number] => 20100305166 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-02 [patent_title] => 'NOVEL COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 12/740216 [patent_app_country] => US [patent_app_date] => 2008-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12822 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0305/20100305166.pdf [firstpage_image] =>[orig_patent_app_number] => 12740216 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11356346 [patent_doc_number] => 09532985 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-01-03 [patent_title] => 'Tetrahydroquinoline derivatives for treating post-traumatic stress disorders' [patent_app_type] => utility [patent_app_number] => 12/681802 [patent_app_country] => US [patent_app_date] => 2008-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 2738 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12681802 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6267537 [patent_doc_number] => 20100298379 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-25 [patent_title] => 'PHARMACEUTICAL COMPOSITIONS OF 5-HYDROXYTRYPTOPHAN AND SEROTONIN-ENHANCING COMPOUND' [patent_app_type] => utility [patent_app_number] => 12/680843 [patent_app_country] => US [patent_app_date] => 2008-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 5355 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0298/20100298379.pdf [firstpage_image] =>[orig_patent_app_number] => 12680843 [rel_patent_id] =>[rel_patent_doc_number] =>)